Here’s whether Pfizer Inc. (PFE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 63 — healthy momentum range; strong 1-year return of +12.6%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.87% over 10 days). Currently 9.4% off its 52-week high. Score: +2/7.
PFE is holding above its long-term 200-day MA ($25.85) but has slipped below the 50-day MA ($26.59), pointing to short-term weakness in an otherwise intact trend. An RSI of 63.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +12.6% compares to +24.4% for SPY (trailed the market by 11.7%).
$10,000 invested 1 year ago→ $11,263 today
vs. S&P 500 (SPY) — same period trailed market by 11.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($25.85)
✗Above 50-day MA ($26.59)
✓RSI(14) neutral zone (30–70) — currently 63.0
✓Positive return (+12.6%)
✓Within 10% of period high (−9.4%)
Period Range $26.04
$23.08$28.75
RSI (14) 63.0
0 · OversoldOverbought · 100
Key Metrics
Price$26.04
Period Return+12.6%
Period High$28.75
Period Low$23.08
Drawdown−9.4%
MA-50$26.59
MA-200$25.85
RSI (14)63.0
Avg Volume (30d)36.0M
vs. SPYtrailed by 11.7%
Return Rank#599 of 1245
Trend Signals
Price is above the 200-day moving average ($25.85)